|
Dr. Pedder joined Chelsea from Hoffmann-La Roche Inc. where he was VP of Pharmaceutical Business, Oncology and an Officer for the company. Prior to that he was in charge of the hepatitis franchise at Roche where he was in charge of the development of Pegasys and Copegus, which have combined annual worldwide sales of over $1 billion. He has been a Director in Pharmaceutical Business, Pharmaceutical Development and Project Management. During his time at Roche he oversaw a number of successful NDAs. Dr. Pedder has his Ph.D. in Pharmacology from the College of Medicine at the University of Saskatchewan in Canada. | 